Pathophysiology, diagnosis, and management of endometriosis

Патофизиология, диагностика и лечение эндометриоза
Andrew W. Horne, Stacey A. Missmer
2022-11-14

chronic inflammatory diseaseendometrial-like tissueendometriosisendometriosis sub-classificationmultimodal interdisciplinary treatment
Endometriosis affects approximately 190 million women and people assigned female at birth worldwide. It is a chronic, inflammatory, gynecologic disease marked by the presence of endometrial-like tissue outside the uterus, which in many patients is associated with debilitating painful symptoms. Patients with endometriosis are also at greater risk of infertility, emergence of fatigue, multisite pain, and other comorbidities. Thus, endometriosis is best understood as a condition with variable presentation and effects at multiple life stages. A long diagnostic delay after symptom onset is common, and persistence and recurrence of symptoms despite treatment is common. This review discusses the potential genetic, hormonal, and immunologic factors that lead to endometriosis, with a focus on current diagnostic and management strategies for gynecologists, general practitioners, and clinicians specializing in conditions for which patients with endometriosis are at higher risk. It examines evidence supporting the different surgical, pharmacologic, and non-pharmacologic approaches to treating patients with endometriosis and presents an easy to adopt step-by-step management strategy. As endometriosis is a multisystem disease, patients with the condition should ideally be offered a personalized, multimodal, interdisciplinary treatment approach. A priority for future discovery is determining clinically informative sub-classifications of endometriosis that predict prognosis and enhance treatment prioritization.
1
Diagnostic delays and persistence or recurrence of symptoms despite treatment are common, highlighting limitations of current care.
2
Endometriosis affects approximately 190 million women and people assigned female at birth worldwide.
3
Endometriosis is associated with increased risks of infertility, fatigue, multisite pain, and other comorbidities across multiple life stages.
4
Future research should identify clinically informative disease subtypes that predict prognosis and guide treatment prioritization.
5
Optimal management should be personalized, multimodal, and interdisciplinary, integrating surgical, pharmacologic, and non-pharmacologic approaches.
6
The disease is chronic and inflammatory, involving endometrial-like tissue outside the uterus and often causing debilitating pain.

Endometriosis as a chronic inflammatory multisystem gynecologic disease

Its pathophysiological mechanisms, variable clinical manifestations, diagnostic delay, treatment persistence and recurrence, and evidence-based personalized multimodal management

Publication Details
Publication Date
2022-11-14
Journal
Publisher
ISSN
Cited by
667
Access Type
Author Information
Authors
Andrew W. Horne
Stacey A. Missmer
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%